Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer

Laura Bracci; Giovanna Schiavoni; Antonella Sistigu; Filippo Belardelli

doi:10.1038/cdd.2013.67

Keywords

Immune systemCytotoxic T cellImmunogenic cell deathBiologyCancer researchImmunologyImmunotherapyCancerCancer cellAcquired immune system

Affiliated Institutions

Istituto Superiore di Sanità IT

Related Publications

Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice

W. Joost Lesterhuis , Cornelis J.A. Punt , Stanleyson V. Hato +11 more

Tumor microenvironments feature immune inhibitory mechanisms that prevent T cells from generating effective antitumor immune responses. Therapeutic interventions aimed at disrup...

2011 Journal of Clinical Investigation 338 citations

Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation

Andrea van Elsas , Arthur A. Hurwitz , James P. Allison

We examined the effectiveness of cytotoxic T lymphocyte–associated antigen 4 (CTLA-4) blockade, alone or in combination with a granulocyte/macrophage colony-stimulating factor (...

1999 The Journal of Experimental Medicine 1010 citations

Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

Haidong Dong , Scott E. Strome , Diva R. Salomão +10 more

B7-H1, a recently described member of the B7 family of costimulatory molecules, is thought to be involved in the regulation of cellular and humoral immune responses through the ...

2002 Nature Medicine 4896 citations

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

Michael A. Curran , Welby Montalvo , Hideo Yagita∥ +1 more

Vaccination with irradiated B16 melanoma cells expressing either GM-CSF (Gvax) or Flt3-ligand (Fvax) combined with antibody blockade of the negative T-cell costimulatory recepto...

2010 Proceedings of the National Academy o... 1833 citations

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

Yoshiko Iwai , Masayoshi Ishida , Yoshimasa Tanaka +3 more

PD-1 is a receptor of the Ig superfamily that negatively regulates T cell antigen receptor signaling by interacting with the specific ligands (PD-L) and is suggested to play a r...

2002 Proceedings of the National Academy o... 3099 citations

Publication Info

Year: 2013
Type: review
Volume: 21
Issue: 1
Pages: 15-25
Citations: 908
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

908

OpenAlex

Cite This

APA Style

                            
                                
                                    Laura Bracci, 
                                
                                    Giovanna Schiavoni, 
                                
                                    Antonella Sistigu
                                
                                et al.
                            
                            (2013). 
                            Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer. 
                            Cell Death and Differentiation
                            , 21
                            (1)
                            , 15-25.
                            https://doi.org/10.1038/cdd.2013.67
                        

Identifiers

DOI: 10.1038/cdd.2013.67